Precision approaches are driving innovation in disease-specific regenerative medicine, where therapies are designed to meet the distinct requirements of conditions like Parkinson’s, type 1 diabetes, and osteoarthritis. By targeting disease mechanisms, researchers employ tailored stem cell lines, responsive scaffolds, and signaling molecules to regenerate affected tissues more effectively. Integration of genetic profiling and cellular engineering enables treatments that address not only structural damage but also underlying pathophysiology. Disease-specific regenerative medicine brings personalized medicine closer to reality by aligning molecular pathology with regenerative tools. This targeted approach reduces risks of immune rejection and improves therapeutic efficacy, especially in chronic and degenerative conditions with limited treatment options.
Title : The era of artificial intelligence (AI) and its use in regenerative medicine
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : The role of gingival fibroblasts in periodontal diseases and regeneration
Katarzyna Gawron, Medical University of Silesia in Katowice, Poland
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Role of textile materials in tissue engineering and regenerative medicine
Gokarneshan Narayanan, SSM College of Engineering (Formerly), India
Title : Induction of neo angiogenesis: A way forward for reversing necrosis in complex wounds in orthopaedic practice
Sandeep Shrivastava, Datta Meghe Institute of Medical Sciences, India
Title : Silk-derived sericin at the interface of atopic dermatitis and wound healing: Modulation of inflammation and epidermal repair
Marek Konop, Medical University of Warsaw, Poland